kras mutation and glutathion Metabolic networks in mutant KRAS-driven tumours: tissue specificities the microenvironment Targeting KRAS Mutant Cancers with
Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv KRAS Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions PMC kras mutation and glutathion glynac Glutathione Depletion Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Isoform Specific Destabilization of the Active
Pay in 4 interest-free payments of $5.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26





